iPharma Tirzepatide 30mg Pre-Filled Pen

Advanced Metabolic Research—Dual-Action Peptide Support

Tirzepatide is a dual GIP/GLP-1 receptor agonist widely researched for its role in metabolic wellness, appetite regulation, and weight-management focused pathways. Supplied in a convenient 30mg pen format, Tirzepatide represents a significant advancement in modern metabolic peptide research.

By targeting both GIP and GLP-1 receptor pathways simultaneously, Tirzepatide has gained attention for its investigational role in appetite, blood sugar, and metabolic wellness support.

 Features & Benefits

30mg Tirzepatide peptide formulation

Convenient injectable pen format

Dual-action GIP and GLP-1 receptor research

Investigated for appetite and satiety pathways

Studied for blood sugar and metabolic wellness support

Associated with weight-management focused research

Research interest in cardiovascular wellness pathways

Widely recognised in metabolic health investigations

How Tirzepatide Works

Tirzepatide is researched for its interaction with:

GIP (Glucose-Dependent Insulinotropic Polypeptide) receptors

GLP-1 (Glucagon-Like Peptide-1) receptors

By targeting both pathways simultaneously, Tirzepatide is studied for effects that may exceed those associated with single-receptor compounds alone.

Research has explored its interaction with appetite, satiety, metabolic balance, and energy-regulation pathways.

Handling & Use

For research use only.

Handle using sterile laboratory procedures.

Store according to packaging instructions.

Use only in controlled research environments.

Important Information

Not approved for human consumption.

Not intended for therapeutic or medical use.

This product is supplied strictly for research purposes only.